Immix Biopharma, Inc. Share Price & Technical Analysis
IMMX · $8.78 (+1.27%)
Healthcare / Biotechnology
$8.78
+1.27%
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-2% return in May, -4% avg return in past 3 year May month.
57% return in 2026, 57% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | 40% | 14% | -3% | -2% | – | – | – | – | – | – | – | 57% |
| 25 | -14% | -5% | -6% | 24% | 10% | -12% | 29% | -19% | -5% | 81% | 11% | 21% | 114% |
| 24 | -44% | -13% | -9% | -29% | -5% | -5% | 5% | 0% | -29% | 7% | 24% | 10% | -88% |
| 23 | 13% | -19% | -14% | 39% | -17% | 29% | -25% | -5% | 70% | 3% | 38% | 33% | 144% |
| 22 | -42% | -29% | -20% | -44% | 50% | 24% | 0% | -25% | -22% | -29% | 9% | 92% | -36% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Neutral
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$532.14M
P/E ratio
—
52W high
$11.61
52W low
$1.87
Volume
25,26,622
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Immix Biopharma, Inc. share price today?
- Immix Biopharma, Inc. (IMMX) last traded around $8.78 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IMMX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IMMX. Download the app for real-time alerts.
- How can I analyze Immix Biopharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.